[Drug modification of double-contrast imaging of the small intestine].
The intravenous use of metoclopramid (paspertin) and ceruletid (Takus) reduces the time required for fractionated double contrast examinations of the small bowel. It also improves visualisation of individual sections of the small bowel, particularly the terminal ileum. The value of these drugs has been assessed in a prospective study in 48 patients with suspected Crohn's disease.
Weidenmaier
W
W
Abteilung für Röntgendiagnostik, Universität Ulm.
Friedrich
J M
JM
Schif
A
A
Schumacher
K A
KA
D001466:Barium Sulfate; D002108:Ceruletide; D003287:Contrast Media / Q000008:administration & dosage*; D003424:Crohn Disease / Q000000981:diagnostic imaging; D004341:Drug Evaluation; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007421:Intestine, Small / Q000000981:diagnostic imaging*; D008747:Methylcellulose / Q000031:analogs & derivatives; D008787:Metoclopramide; D011446:Prospective Studies; D011859:Radiography; D013997:Time Factors
D003287:Contrast Media; D001466:Barium Sulfate; D002108:Ceruletide; C013124:methylethylcellulose; D008747:Methylcellulose; D008787:Metoclopramide
Medikamentöse Beeinflussung der fraktionierten Dünndarmdoppelkontrastdarstellung.